- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Report
- January 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Report
- July 2026
- 148 Pages
Global
From €4335EUR$4,750USD£3,715GBP
- Report
- June 2026
- 111 Pages
Global
From €4335EUR$4,750USD£3,715GBP
- Report
- April 2026
- 180 Pages
Global
From €4335EUR$4,750USD£3,715GBP
- Report
- April 2026
- 135 Pages
Global
From €4335EUR$4,750USD£3,715GBP
- Report
- August 2026
- 150 Pages
Global
From €3605EUR$3,950USD£3,089GBP
- Report
- August 2026
- 160 Pages
Global
From €3030EUR$3,320USD£2,597GBP
€3788EUR$4,150USD£3,246GBP
- Report
- August 2026
- 160 Pages
Global
From €3030EUR$3,320USD£2,597GBP
€3788EUR$4,150USD£3,246GBP
- Report
- August 2026
- 160 Pages
Global
From €3030EUR$3,320USD£2,597GBP
€3788EUR$4,150USD£3,246GBP
- Report
- July 2026
- 160 Pages
Global
From €3030EUR$3,320USD£2,597GBP
€3788EUR$4,150USD£3,246GBP
- Report
- July 2026
- 160 Pages
Global
From €3030EUR$3,320USD£2,597GBP
€3788EUR$4,150USD£3,246GBP
- Report
- June 2026
- 160 Pages
Global
From €2555EUR$2,799USD£2,189GBP
€3194EUR$3,499USD£2,737GBP
- Report
- April 2026
- 160 Pages
Global
From €3030EUR$3,320USD£2,597GBP
€3788EUR$4,150USD£3,246GBP
- Report
- April 2026
- 160 Pages
Global
From €3030EUR$3,320USD£2,597GBP
€3788EUR$4,150USD£3,246GBP
- Report
- October 2025
- 140 Pages
Global
From €4427EUR$4,850USD£3,793GBP
- Report
- September 2026
- 157 Pages
Europe
From €4472EUR$4,900USD£3,832GBP

The Multiomics market is a subset of the Genomics market, focusing on the analysis of multiple types of omics data. This includes data from genomics, transcriptomics, proteomics, metabolomics, and epigenomics. Multiomics data can be used to gain a more comprehensive understanding of biological systems, such as the interactions between genes, proteins, and metabolites. This data can be used to develop new diagnostics, treatments, and therapies for a variety of diseases.
Multiomics technology is rapidly advancing, with new tools and techniques being developed to improve the accuracy and speed of data analysis. This technology is being used in a variety of industries, including healthcare, agriculture, and biotechnology.
Some companies in the Multiomics market include Illumina, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, and Bio-Rad Laboratories. Show Less Read more